Additionally, Chm-1 expression was shown to be downregulated in gastric cancer, and Chm-1 appears to be a potential tumour suppressor, that may also be an important biomarker for the treatment and prognosis of gastric cancer [46]. This evidence concerns the gene CNMD and gastric cancer.